A detailed history of Arizona State Retirement System transactions in Abb Vie Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 506,318 shares of ABBV stock, worth $90.3 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
506,318
Previous 513,321 1.36%
Holding current value
$90.3 Million
Previous $88 Million 13.56%
% of portfolio
0.64%
Previous 0.6%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $1.15 Million - $1.4 Million
-7,003 Reduced 1.36%
506,318 $100 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $1.03 Million - $1.21 Million
6,671 Added 1.32%
513,321 $88 Million
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $1.61 Million - $1.83 Million
10,065 Added 2.03%
506,650 $92.3 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $385,555 - $434,225
-2,802 Reduced 0.56%
496,585 $77 Million
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $652,587 - $755,465
-4,885 Reduced 0.97%
499,387 $74.4 Million
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $2.84 Million - $3.53 Million
21,402 Added 4.43%
504,272 $67.9 Million
Q1 2023

Apr 27, 2023

BUY
$144.61 - $166.54 $161,095 - $185,525
1,114 Added 0.23%
482,870 $77 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $195,017 - $233,876
1,410 Added 0.29%
481,756 $77.9 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $658,165 - $754,872
-4,904 Reduced 1.01%
480,346 $64.5 Million
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $19,954 - $25,369
145 Added 0.03%
485,250 $74.3 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $146,497 - $181,762
1,110 Added 0.23%
485,105 $78.6 Million
Q4 2021

Feb 04, 2022

SELL
$107.43 - $135.93 $917,129 - $1.16 Million
-8,537 Reduced 1.73%
483,995 $65.5 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $236,740 - $268,735
-2,225 Reduced 0.45%
492,532 $53.1 Million
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $290,484 - $323,616
-2,761 Reduced 0.55%
494,757 $55.7 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $1.2 Million - $1.32 Million
-11,690 Reduced 2.3%
497,518 $53.8 Million
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $2.25 Million - $3.04 Million
-27,930 Reduced 5.2%
509,208 $54.6 Million
Q3 2020

Nov 05, 2020

BUY
$85.91 - $100.83 $10.5 Million - $12.3 Million
122,247 Added 29.46%
537,138 $47 Million
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $10.9 Million - $14.6 Million
148,998 Added 56.04%
414,891 $40.7 Million
Q1 2020

May 05, 2020

SELL
$64.5 - $97.79 $760,519 - $1.15 Million
-11,791 Reduced 4.25%
265,893 $20.3 Million
Q4 2019

Jan 27, 2020

BUY
$72.13 - $90.25 $116,273 - $145,483
1,612 Added 0.58%
277,684 $24.6 Million
Q3 2019

Oct 31, 2019

SELL
$62.98 - $75.72 $320,820 - $385,717
-5,094 Reduced 1.81%
276,072 $20.9 Million
Q2 2019

Jul 25, 2019

SELL
$65.7 - $83.98 $136,393 - $174,342
-2,076 Reduced 0.73%
281,166 $20.4 Million
Q1 2019

Apr 29, 2019

SELL
$77.14 - $90.79 $1.99 Million - $2.34 Million
-25,821 Reduced 8.35%
283,242 $22.8 Million
Q4 2018

Jan 28, 2019

SELL
$77.85 - $96.01 $5.16 Million - $6.36 Million
-66,256 Reduced 17.65%
309,063 $28.5 Million
Q3 2018

Oct 29, 2018

BUY
$88.91 - $98.84 $268,508 - $298,496
3,020 Added 0.81%
375,319 $35.5 Million
Q2 2018

Aug 07, 2018

SELL
$89.78 - $106.23 $3.39 Million - $4.01 Million
-37,787 Reduced 9.21%
372,299 $34.5 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $1.22 Million - $1.64 Million
-13,300 Reduced 3.14%
410,086 $38.8 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $2.53 Million - $2.77 Million
28,210 Added 7.14%
423,386 $40.9 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $27.6 Million - $35.3 Million
395,176
395,176 $35.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.